Combination therapy of PEG-interferon and ribavirin for chronic hepatitis C in Japan
Arase, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 191-195
2011
ISSN/ISBN: 0047-1852 PMID: 22096917 Document Number: 654962
Document emailed within 1 workday
Related Documents
Ferenci, P. 2006: Pegylated interferon plus ribavirin for chronic hepatitis C: the role of combination therapy today, tomorrow and in the future Minerva Gastroenterologica e Dietologica 52(2): 157-174Bolukbas, C.; Bolukbas, F.F.; Kebdir, T.; Canayaz, L.; Dalay, A.R.; Kilic, G.; Ovunc, O. 2005: Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature Acta Gastro-Enterologica Belgica 68(4): 432-434
Khokhar, N. 2002: Effectiveness of 48 weeks Interferon alfa-2b in combination with ribavirin as initial treatment of chronic hepatitis Journal of Ayub Medical College Abbottabad: Jamc 14(3): 5-8
Husa, P.; Husova, L. 2001: Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons Bratislavske Lekarske Listy 102(5): 248-252
Gunsar, F.; Akarca, U.S.; Ersoz, G.; Kobak, A.C.; Karasu, Z.; Yuce, G.; Ilter, T.; Batur, Y. 2005: Two-year interferon therapy with or without ribavirin in chronic delta hepatitis Antiviral Therapy 10(6): 721-726
Sajjad, S.F.; Ahmed, W.u.; Arif, A.; Alam, S.E.; Waquar, J. 2012: Weight loss with interferon and ribavirin therapy in chronic hepatitis C patients JPMA. Journal of the Pakistan Medical Association 62(11): 1229-1232
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Nevens, F.; Van Vlierberghe, H.; D'Heygere, E.; Delwaide, J.; Adler, M.; Henrion, J.; Lenaerts, A.; Hendlisz, A.; Michielsen, P.; Bastens, B.; Brenard, R.; Laureys, A. 2010: A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients Acta Gastro-Enterologica Belgica 73(2): 223-228
Abe, Y.; Ueda, T.; Kato, T.; Kohli, Y. 1994: Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 52(7): 1817-1822
Nakamura, H.; Uyama, H.; Enomoto, H.; Kishima, Y.; Yamamoto, M.; Yoshida, K.; Okuda, Y.; Hirotani, T.; Kuroda, T.; Ito, H.; Matsuda, M.; Terabayashi, M.; Noguchi, S. 2003: The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C Hepato-Gastroenterology 50(49): 222-226
Juszczyk, J.; Baka-Cwierz, B.; Beniowski, M.; Berak, H.; Bolewska, B.; Boroń-Kaczmarska, A.; Cianciara, J.; Cieśla, A.; Dziambor, A.; Gasiorowski, J.; Gietka, A.; Gliwińska, E.; Gładysz, A.; Gonciarz, Z.; Halota, W.; Horban, A.; Inglot, Młgorzata.; Janas-Skulina, U.; Janczewska-Kazek, E.; Jaskowska, J.; Jurczyk, K.; Knysz, B.; Kryczka, Wław.; Kuydowicz, J.; Lakomy, E.A.; Logiewa-Bazger, B.; Lyczak, A.; Mach, T.; Mazur, Włodzimierz.; Michalska, Z.; Modrzewska, R.; Nazzal, K.; Pabjan, Pł.; Piekarska, A.; Piszko, Pł.; Sikorska, K.; Szamotulska, K.; Sliwińska, M 2005: Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report) Przeglad Epidemiologiczny 59(3): 651-660
Słuzewski, W.; Kowala-Piaskowska, A.; Wysocki, J.; Figlerowicz, M.; Gorczyca, A.; Halota, W.; Jóźwiak, H.; Mizerski, J.; Mozer-Lisewska, I.; Pawłowska, M.łg.; Rokitka, M.; Strawińska, E.; Szamotulska, K. 2012: Treatment of chronic hepatitis C in children with pegylated interferon α2a and ribavirin--a multi-center study Acta Poloniae Pharmaceutica 69(2): 319-326
Saitta, C.; Pontisso, P.; Brunetto, M.R.; Fargion, S.; Gaeta, G.B.; Niro, G.A.; Picciotto, A.; Smedile, A.; Squadrito, G.; Raimondo, G. 2006: Virological profiles in hepatitis B virus/hepatitis C virus coinfected patients under interferon plus ribavirin therapy Antiviral Therapy 11(7): 931-934
Jurczyk, K.; Karpińska, E.; Wawrzynowicz-Syczewska, M.; Morańska, I.; Noceń, I.; Chlubek, D.; Boroń-Kaczmarska, A. 2008: State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin Hepato-Gastroenterology 55(82-83): 557-561
Yu, J.; Liu, B.-w.; Lan, L.; Yuan, Y.; Zhang, H.; Jia, C.-h. 2010: Efficacy of peginterferon alpha-2a in combination with ribavirin in treatment of eldly patients with chronic hepatitis C Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 24(5): 373-375
Mozer-Lisewska, I.; Dworacki, G.; Kaczmarek, E.; Słuzewski, W.; Kowala-Piaskowska, A.; Figlerowicz, M.; Kaczmarek, M.; Zeromski, J. 2005: Alterations within white blood cell subsets in children with chronic viral hepatitis C before treatment with pegylated interferon and ribavirin Przeglad Epidemiologiczny 59(2): 483-489
Chu, C-Jen.; Wang, Y-Jen.; Hwang, S-Jang.; Lu, R-Hwa.; Chang, F-Young.; Chang, C-Yu.; Yang, Y-Chun.; Lee, S-Dong. 2007: Kinetics of hepatitis C virus RNA load during pegylated interferon plus ribavirin therapy in Treatment-naive Chinese patients Hepato-Gastroenterology 54(75): 866-870
Hamidah, A.; Yong, J.F.; Zulkifli, H.I.; Jamal, R. 2002: Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia Medical Journal of Malaysia 57(3): 353-356